Furiex Pharmaceuticals (FURX) SC 13D Furiex Pharmaceuticals / KINGSTOWN CAPITAL MANAGEMENT ownership change

Exhibit 99.1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D, dated July 9, 2010 (including amendments thereto), with respect to the securities of Furiex Pharmaceuticals, Inc.  This Joint Filing Agreement shall be filed as an Exhibit to such Statement.

Date: July 9, 2010	KINGSTOWN CAPITAL MANAGEMENT L.P.
	By:		Kingstown Management GP LLC
			its general partner
	By:	/s/ Michael Blitzer
		Michael Blitzer Managing Member

KINGSTOWN MANAGEMENT GP LLC
By:	/s/ Michael Blitzer
	Michael Blitzer Managing Member

KINGSTOWN PARTNERS MASTER LTD.
By:	/s/ Michael Blitzer
	Michael Blitzer Director

/s/ Michael Blitzer

MICHAEL BLITZER

/s/ Guy Shanon

GUY SHANON